Microsoft launches Copilot Health AI preview for US users

Copilot Health’s preview is another data point in a clear trend: the big AI players are racing to own high‑value, high‑sensitivity verticals, and healthcare is at the front of the line. By offering a consumer-facing interface that unifies wearables, lab results, and electronic health records, Microsoft is building both a powerful testbed for health‑oriented AI agents and a strong moat around longitudinal, labeled data. The product is framed as guidance rather than diagnosis, but in practice it trains users to consult an AI copilot as a first stop for understanding their bodies.

From an AGI perspective, this kind of structured, real‑world decision data is gold. Health questions force models to reason under uncertainty, reconcile conflicting signals, and align outputs with conservative safety constraints. If Microsoft can scale Copilot Health while keeping regulators comfortable about privacy and bias, it will gain a durable edge in reinforcement signals and human‑in‑the‑loop feedback that general‑purpose models rarely see. At the same time, the move raises the stakes for competitors like OpenAI and Anthropic, who will face pressure to show equally compelling, safe health use cases without overstepping into regulated medical practice.